| Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial G Lombardi, GL De Salvo, AA Brandes, M Eoli, R Rudà, M Faedi, I Lolli, ... The Lancet Oncology 20 (1), 110-119, 2019 | 298 | 2019 |
| Bevacizumab for the treatment of radiation-induced cerebral necrosis: a systematic review of the literature D Delishaj, S Ursino, F Pasqualetti, A Cristaudo, M Cosottini, MG Fabrini, ... Journal of clinical medicine research 9 (4), 273, 2017 | 89 | 2017 |
| Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology) R Soffietti, E Trevisan, L Bertero, P Cassoni, I Morra, MG Fabrini, ... Journal of neuro-oncology 116, 533-541, 2014 | 87 | 2014 |
| Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study L Triggiani, R Mazzola, SM Magrini, G Ingrosso, P Borghetti, F Trippa, ... World journal of urology 37, 2631-2637, 2019 | 84 | 2019 |
| [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results F Pasqualetti, M Panichi, A Sainato, F Matteucci, L Galli, P Cocuzza, ... Radiation Oncology 11, 1-8, 2016 | 77 | 2016 |
| Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature D Delishaj, A Rembielak, B Manfredi, S Ursino, F Pasqualetti, C Laliscia, ... Journal of Contemporary Brachytherapy 8 (6), 533-540, 2016 | 72 | 2016 |
| Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and … C Bianco, E Giovannetti, F Ciardiello, V Mey, S Nannizzi, G Tortora, ... Clinical cancer research 12 (23), 7099-7107, 2006 | 70 | 2006 |
| Decipher the glioblastoma microenvironment: the first milestone for new groundbreaking therapeutic strategies GN Fanelli, D Grassini, V Ortenzi, F Pasqualetti, N Montemurro, P Perrini, ... Genes 12 (3), 445, 2021 | 62 | 2021 |
| Clinical management of diffuse low-grade gliomas G Lombardi, V Barresi, A Castellano, E Tabouret, F Pasqualetti, ... Cancers 12 (10), 3008, 2020 | 61 | 2020 |
| Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients E Baldini, A Camerini, A Sgambato, T Prochilo, A Capodanno, ... Anticancer research 26 (6B), 4415-4421, 2006 | 58 | 2006 |
| Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series D Delishaj, C Laliscia, B Manfredi, S Ursino, F Pasqualetti, E Lombardo, ... Journal of contemporary brachytherapy 7 (6), 437-444, 2015 | 55 | 2015 |
| Laser capture microdissection and RNA-seq analysis: High sensitivity approaches to explain histopathological heterogeneity in human glioblastoma FFPE archived tissues P Civita, S Franceschi, P Aretini, V Ortenzi, M Menicagli, F Lessi, ... Frontiers in oncology 9, 482, 2019 | 52 | 2019 |
| Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis P Perrini, C Gambacciani, A Weiss, F Pasqualetti, D Delishaj, F Paiar, ... Journal of neuro-oncology 131, 585-591, 2017 | 50 | 2017 |
| Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series N Montemurro, GN Fanelli, C Scatena, V Ortenzi, F Pasqualetti, ... Clinical Neurology and Neurosurgery 207, 106735, 2021 | 48 | 2021 |
| Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter … G Lombardi, A Pace, F Pasqualetti, S Rizzato, M Faedi, E Anghileri, ... Journal of neuro-oncology 125, 359-367, 2015 | 47 | 2015 |
| Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) P Navarria, G Minniti, E Clerici, S Tomatis, V Pinzi, P Ciammella, ... Journal of neuro-oncology 142, 59-67, 2019 | 46 | 2019 |
| Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO S Scoccianti, E Olmetto, V Pinzi, MF Osti, R Di Franco, S Caini, P Anselmo, ... Neuro-oncology 23 (10), 1750-1764, 2021 | 40 | 2021 |
| Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas MG Fabrini, F Perrone, L De Franco, F Pasqualetti, S Grespi, R Vannozzi, ... Strahlentherapie und Onkologie 185 (8), 524, 2009 | 40 | 2009 |
| Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results D Delishaj, A Barcellini, R D’Amico, S Ursino, F Pasqualetti, IC Fumagalli, ... Journal of Contemporary Brachytherapy 10 (6), 559-566, 2018 | 39 | 2018 |
| A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer F Pietrantonio, G Aprile, L Rimassa, P Franco, S Lonardi, C Cremolini, ... Radiotherapy and Oncology 117 (2), 315-321, 2015 | 39 | 2015 |
